Cures and therapies with curative intent are here in hepatitis C and are coming in other serious diseases. So everyone, from pharma suppliers patients, is scrambling to figure out what this means, writes Mike Rutstein.
Mike Rutstein
Advertisement
Mike Rutstein, Founder and CEO of STRIKEFORCE COMMUNICATIONSmrutstein@strikeforcenyc.comstrikeforcenyc.com.
Articles by Mike Rutstein
Advertisement
Latest Updated Articles
- "There's a Cure for That..."
Published: May 19th 2015 | Updated:
Advertisement
Advertisement
Trending on PharmExec
1
Pharmaceutical Executive Daily: Pfizer Files Lawsuits Against Metsera and Novo Nordisk
2
FDA Approves Kygevvi Becoming the First Treatment for Thymidine Kinase 2 Deficiency
3
Join Us Tonight: Inside Trump’s Drug Price Plan
4
Roundup: Biotech’s Most Recent Strategic Partnerships and Exclusive Licensing Agreements
5
